Dr D’Amato discusses research in sarcoma and gastrointestinal stromal tumor, incorporating circulating tumor DNA analysis into routine reevaluation of patients with progressive disease, and the importance of establishing a drug’s clinical profile in non–trial target ethnic populations.
Welcome to OncLive On Air®! I’m your host today, Caroline Seymour.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, sponsored by Deciphera Pharmaceuticals, we had the pleasure of speaking with Gina Z. D’Amato, MD, to discuss research in sarcoma and gastrointestinal stromal tumor that was presented at the 2022 ASCO Annual Meeting, 2023 Gastrointestinal Cancers Symposium, and 2023 January ASCO Plenary Series.
Dr D’Amato is an associate professor of medicine and sarcoma medical oncology and the assistant director of clinical research at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System in Florida.
In our exclusive interview, Dr D’Amato discussed the significance of incorporating circulating tumor DNA analysis into routine reevaluation of patients with progressive disease, emphasized the importance of establishing a drug’s clinical profile in non–trial target ethnic populations, and highlighted a first-in-human trial evaluating IDRX-42, a novel TKI that could overcome acquired resistance to standard therapy.
That’s all we have for today! Thank you for listening to this episode of OncLive On Air®, sponsored by Deciphera Pharmaceuticals. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air®.
*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.